Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
$63.05
+0.3%
$61.68
$52.97
$63.08
$2.63B0.61250,780 shs158,984 shs
American Resources Corporation stock logo
AREC
American Resources
$2.05
-6.2%
$1.26
$0.38
$2.49
$173.87M0.893.55 million shs4.33 million shs
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
$2.29
+1.1%
$2.70
$0.90
$3.35
$85.94M-0.09170,740 shs31,752 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
-0.02%+0.61%+1.68%+5.52%+7.99%
American Resources Corporation stock logo
AREC
American Resources
+3.81%+65.15%+80.17%+225.42%+296.80%
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
-5.44%-8.13%-17.22%+20.86%+107.34%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
American Resources Corporation stock logo
AREC
American Resources
2.9638 of 5 stars
3.54.00.00.03.10.80.6
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
3.141 of 5 stars
3.55.00.00.03.31.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
0.00
N/AN/AN/A
American Resources Corporation stock logo
AREC
American Resources
3.00
Buy$4.0095.60% Upside
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
3.00
Buy$7.00206.35% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/AN/AN/AN/AN/A
American Resources Corporation stock logo
AREC
American Resources
$380K455.34N/AN/A($1.09) per share-1.88
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
N/AN/AN/AN/A($0.16) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/A19.83N/AN/AN/AN/AN/A
American Resources Corporation stock logo
AREC
American Resources
-$40.11M-$0.49N/A34.08N/A-13,152.00%N/A-21.17%11/13/2025 (Estimated)
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
-$4.71MN/A0.00N/AN/AN/AN/AN/AN/A

Latest HEMO, AREC, OKYO, and AOR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2025Q2 2025
American Resources Corporation stock logo
AREC
American Resources
-$0.05-$0.10-$0.05-$0.10$16.40 million$0.01 million
6/10/2025Q4 2024
American Resources Corporation stock logo
AREC
American Resources
-$0.05-$0.24-$0.19-$0.24$1.30 million$0.05 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
$1.592.52%N/AN/AN/A
American Resources Corporation stock logo
AREC
American Resources
N/AN/AN/AN/AN/A
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/AN/A
American Resources Corporation stock logo
AREC
American Resources
N/A
0.12
0.10
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
N/A
0.40
0.40

Institutional Ownership

CompanyInstitutional Ownership
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/A
American Resources Corporation stock logo
AREC
American Resources
9.32%
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
2.97%

Insider Ownership

CompanyInsider Ownership
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/A
American Resources Corporation stock logo
AREC
American Resources
16.80%
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
40.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/A41.75 millionN/ANot Optionable
American Resources Corporation stock logo
AREC
American Resources
1084.61 million70.40 millionOptionable
OKYO Pharma Limited Sponsored ADR stock logo
OKYO
OKYO Pharma
737.61 million22.39 millionNot Optionable

Recent News About These Companies

OKYO Slides Despite Fresh R&D Funding

New MarketBeat Followers Over Time

Media Sentiment Over Time

iShares Core 60/40 Balanced Allocation ETF stock logo

iShares Core 60/40 Balanced Allocation ETF NYSEARCA:AOR

$63.04 +0.21 (+0.33%)
As of 03:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile. The Fund is designed for investors seeking moderate capital appreciation and opportunity for current income and capital preservation. The Fund's investment advisor is BlackRock Fund Advisors.

American Resources stock logo

American Resources NASDAQ:AREC

$2.04 -0.14 (-6.19%)
As of 03:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

American Resources Corporation, together with its subsidiaries, extracts, processes, transports, and sells metallurgical coal to the steel and industrial industries. It supplies raw materials; and sells coal used in pulverized coal injections. The company was founded in 2006 and is headquartered in Fishers, Indiana.

OKYO Pharma stock logo

OKYO Pharma NASDAQ:OKYO

$2.28 +0.03 (+1.11%)
As of 03:08 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.